Name: | Description: | Size: | Format: | |
---|---|---|---|---|
1.03 MB | Adobe PDF |
Advisor(s)
Abstract(s)
Behçet disease is a chronic relapsing systemic disease with possible life-threatening presentations. Management of this disease can be challenging and reports of the off-label use of anti-TNFα agents for the treatment of severe manifestations are increasing, with good results. The authors report a case of Behçet disease with a sudden and severe multi-systemic onset successfully treated with infliximab.
Description
Keywords
Citation
Dermatology Online Journal 19 (4): 18
Publisher
University of California